Skip to main content

Month: May 2024

Soitec Reports Fourth Quarter Revenue and Full-Year Results of Fiscal Year 2024

            SOITEC REPORTS FOURTH QUARTER REVENUE ANDFULL-YEAR RESULTS OF FISCAL YEAR 2024Q4’24 revenue reached €337m, down 2% at constant exchange rates and perimeter compared to the record quarter Q4’23 FY’24 revenue amounted to €978m, down 10% both at constant exchange rates and perimeter and on a reported basis, in line with latest guidance FY’24 EBITDA1 margin2 at the level of 34%, also in line with latest guidance FY’24 net profit, reached €178m, an 18% margin FY’25 outlook confirmed: Soitec expects revenue to be stable year-on-year at constant exchange rates and perimeter and EBITDA1 margin2 to reach around 35% Changes in the Board of Directors: Frédéric Lissalde to be proposed as Director at the next Annual General MeetingBernin (Grenoble), France, May 22nd, 2024 – Soitec (Euronext Paris), a world leader in designing and manufacturing...

Continue reading

Transcontinental Inc. – Release of Second Quarter 2024 Results and Conference Call

MONTRÉAL, May 22, 2024 (GLOBE NEWSWIRE) — On Wednesday, June 5, 2024, Transcontinental Inc. will release its second quarter 2024 results after market close. The financial results will be made public in a press release that will be issued on the newswire as well as in the Management’s Discussion and Analysis that will be posted on the Corporation’s website. The Corporation will also host a conference call for the financial community on Thursday, June 6, at 8:00 a.m. The conference call will be broadcast live (audio only) on the Investors homepage of the Corporation’s website at www.tc.tc, and will be archived for 30 days.Q2-2024 Results Conference Call   Date: Thursday, June 6, 2024Time: 8:00 AMDial-in numbers: 1-289-514-5100 or 1-800-717-1738Live audio webcast: www.tc.tc/investors    Conference Recording...

Continue reading

Park Aerospace Corp. Reports Storm Damage to Its Newton, Kansas Manufacturing Facilities

NEWTON, Kan., May 22, 2024 (GLOBE NEWSWIRE) — Park Aerospace Corp. (NYSE-PKE) reported that, on Sunday, May 19, at approximately 8:00 pm local time, the Company’s Newton, Kansas manufacturing facilities were damaged by a strong storm which transitioned the area. None of the Company’s manufacturing lines or equipment were damaged by the storm. Although the building structures are secure, it is likely that the roofs on all three buildings in the Company’s Newton, Kansas campus will ultimately need to be replaced. Also, multiple specialty HVAC units were damaged or destroyed. These specialty HVAC units are necessary to control the temperature and humidity in certain of the manufacturing rooms and the production and R&D laboratories, which is required by certain specifications and certifications the Company is subject to. The...

Continue reading

Kymera Therapeutics Presents New Preclinical Data for KT-621, a First-In-Class, Oral STAT6 Degrader at the ATS Annual Meeting

KT-621, a potent, selective, oral STAT6 degrader, demonstrated comparable or superior activity to dupilumab in preclinical studies including an asthma model shared at the ATS Annual Meeting Additional KT-621 preclinical data was also featured in a poster presentation at Digestive Disease Week KT-621 expected to start Phase 1 in the second half of 2024,with Phase 1 data in the first half of 2025 WATERTOWN, Mass., May 22, 2024 (GLOBE NEWSWIRE) — Kymera Therapeutics, Inc. (NASDAQ: KYMR), a clinical-stage biopharmaceutical company advancing a new class of small molecule medicines using targeted protein degradation (TPD), today announced the presentation of additional preclinical data for KT-621, a potent, selective, oral heterobifunctional degrader of STAT6, at the American Thoracic Society (ATS) Annual Meeting in San Diego, California....

Continue reading

Bion Gives Company Update

New York, NY, May 22, 2024 (GLOBE NEWSWIRE) — Bion Environmental Technologies, Inc. (OTC QB: BNET), a leader in advanced livestock waste treatment technology and premium sustainable beef, gave the following company update: We have faced several challenges in the last year that began with the construction delays at Fair Oaks and were complicated by ongoing management transition issues (resulting from the passing of our long-term CEO/COO). As a result, we have been unable to raise sufficient capital through our traditional retail sources. We are exploring all strategic options to raise capital and propel the company forward.  We knew that building a team and platform to commercialize our technology would require substantial strategic investment.  We are optimistic about our ongoing conversations with potential clean energy, utility,...

Continue reading

G1 Therapeutics to Participate in TD Cowen’s 5th Annual Oncology Innovation Summit

RESEARCH TRIANGLE PARK, N.C., May 22, 2024 (GLOBE NEWSWIRE) — G1 Therapeutics, Inc. (Nasdaq: GTHX), a commercial-stage oncology company, today announced that G1’s Chief Medical Officer Dr. Raj Malik and Chief Commercial Officer Andrew Perry will participate in a fireside chat at TD Cowen’s 5th Annual Oncology Innovation Summit: Insights for ASCO & EHA, on Wednesday, May 29, at 8:30AM EDT. The webcast of the event will be accessible on the Events & Presentations page of http://www.g1therapeutics.com. About G1 TherapeuticsG1 Therapeutics, Inc. is a commercial-stage oncology biopharmaceutical company whose mission is to develop and deliver next-generation therapies that improve the lives of those affected by cancer, including the Company’s first commercial product, COSELA® (trilaciclib). The Company is also evaluating therapies...

Continue reading

Power Engineering Corporation (PEC), a subsidiary of JP 3E Holdings, Inc. (OTC: SPZI), Announces Joint Venture with Bloxcross

CLEARWATER, Fla., May 22, 2024 (GLOBE NEWSWIRE) — Power Engineering Corporation (PEC), a subsidiary of JP 3E Holdings, Inc., formerly Spooz, Inc. (OTC: SPZI) announces a joint venture with Bloxcross (BLOX) to expand business operations in the Middle East and North Africa (MENA) region. This venture will focus on the Oil and Gas, Healthcare, Construction, and Commodities sectors.https://www.pec.com.qa/https://www.blox.global/ The initial transaction will begin with PEC’s dedicated Oil and Gas vertical. Blox will finance its current trading activities. This Memorandum of Agreement (MOA) outlines the steps to implement the Trade Financing Platform for PEC’s global trade deals. PEC will direct trade transactions through its subsidiaries and partners to Blox for funding and payment processing. In return, Blox will provide substantial...

Continue reading

Form 8.3 – [MATTIOLI WOODS PLC – 21 05 2024] – (CGWL)

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.        KEY INFORMATION(a)   Full name of discloser: CANACCORD GENUITY WEALTH LIMITED (for Discretionary clients)(b)   Owner or controller of interests and short positions disclosed, if different from 1(a):        The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. N/A(c)   Name of offeror/offeree in relation to whose relevant securities this form relates:        Use a separate form for each offeror/offeree MATTIOLI WOODS PLC(d)   If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: MATTIOLI WOODS PLC AS AN ASSOCIATE...

Continue reading

Crown Castle Announces Shareholders Have Elected All 12 of the Company’s Director Nominees

Results Reflect Support for Ongoing Value Creation Initiatives HOUSTON, May 22, 2024 (GLOBE NEWSWIRE) — Crown Castle Inc. (NYSE: CCI) (“Crown Castle” or the “Company”) announced today that, based on preliminary information from the Company’s proxy solicitor, Crown Castle’s entire slate of 12 nominees has been elected to the Company’s Board of Directors (“Board”) at the 2024 Annual Meeting of Stockholders. The Company issued the following statement: We thank our shareholders for the trust they have placed in our highly qualified board members as they oversee the creation of a stronger, more valuable Crown Castle. Along with our new CEO, Steven Moskowitz, the board continues to take action, including conducting the strategic and operational review of our fiber and small cell business already underway, to improve...

Continue reading

HEALWELL AI Closes Upsized $20 Million Bought Deal Offering

NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES TORONTO, May 22, 2024 (GLOBE NEWSWIRE) — HEALWELL AI INC. (“HEALWELL” or the “Company”) (TSX: AIDX) is pleased to announce today that it has closed its previously announced “bought deal” private placement offering and issued 14,815,000 units of the Company (the “Units”) at a price of $1.35 per Unit, for aggregate gross proceeds of $20,000,250 (the “Offering”). Dr. Alexander Dobranowski, CEO of HEALWELL commented, “In addition to strengthening the Company’s balance sheet, the completion of the Offering positions the Company well to carry out the remainder of its 2024 growth initiatives. This milestone marks not just a financial achievement but a significant step towards realizing our mission to improve healthcare and save lives through the...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.